Author:
Kostrzewa-Nowak D,Paine M J I,Wolf C R,Tarasiuk J
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Adams GE, Stratford IJ (1994) Bioreductive drugs for cancer therapy: the search for tumor specificity. Int J Radiat Oncol Biol Phys 29: 231–238
2. Bailey SM, Lewis AD, Patterson LH, Fisher GR, Knox RJ, Workman P (2001) Involvement of NADPH: cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging species. Biochem Pharmacol 62: 461–468
3. Bartoszek A (2002) Metabolic activation of adriamycin by NADPH-cytochrome P450 reductase; overview of its biological and biochemical effects. Acta Biochim Pol 49: 323–331
4. Bartoszek A, Pawlowska J, Tarasiuk J (1999) Adriamycin metabolism mediated by NADPH cytochrome P-450 reductase: NADPH consumption and radical formation. 7th International Symposium on Molecular Aspects of Chemotherapy, Gdansk, 8–11 September 1999, Poland, Abstract Book, p. 90
5. Bartoszek A, Wolf CR (1992) Enhancement of doxorubicin toxicity following activation by NADPH cytohrome P450 reductase. Biochem Pharmacol 43: 1449–1457
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献